Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1992 Sep 26;305(6856):729–730. doi: 10.1136/bmj.305.6856.729

Managing recurrent malignant pericardial effusions.

D Keane, G Jackson
PMCID: PMC1883404  PMID: 1384895

Full text

PDF
729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis S., Rambotti P., Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol. 1984 Jun;2(6):631–636. doi: 10.1200/JCO.1984.2.6.631. [DOI] [PubMed] [Google Scholar]
  2. Fairlamb D. J. External radiotherapy in the management of malignant pericardial effusion. Clin Radiol. 1989 May;40(3):307–308. doi: 10.1016/s0009-9260(89)80215-6. [DOI] [PubMed] [Google Scholar]
  3. Fentiman I. S. Diagnosis and treatment of malignant pleural effusions. Cancer Treat Rev. 1987 Jun;14(2):107–118. doi: 10.1016/0305-7372(87)90043-0. [DOI] [PubMed] [Google Scholar]
  4. Figoli F., Zanette M. L., Tirelli U., Sorio R., Lestuzzi C., Urso R., Monfardini S., D'Incalci M. Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion. Cancer Chemother Pharmacol. 1987;20(3):239–242. doi: 10.1007/BF00570493. [DOI] [PubMed] [Google Scholar]
  5. Firusian N. 32P-Therapie des malignen Perikardergusses. Onkologie. 1980 Feb;3(1):12–17. doi: 10.1159/000214737. [DOI] [PubMed] [Google Scholar]
  6. Imamura T., Tamura K., Takenaga M., Nagatomo Y., Ishikawa T., Nakagawa S. Intrapericardial OK-432 instillation for the management of malignant pericardial effusion. Cancer. 1991 Jul 15;68(2):259–263. doi: 10.1002/1097-0142(19910715)68:2<259::aid-cncr2820680207>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  7. Markiewicz W., Borovik R., Ecker S. Cardiac tamponade in medical patients: treatment and prognosis in the echocardiographic era. Am Heart J. 1986 Jun;111(6):1138–1142. doi: 10.1016/0002-8703(86)90018-9. [DOI] [PubMed] [Google Scholar]
  8. Mills S. A., Julian S., Holliday R. H., Vinten-Johansen J., Case L. D., Hudspeth A. S., Tucker W. Y., Cordell A. R. Subxiphoid pericardial window for pericardial effusive disease. J Cardiovasc Surg (Torino) 1989 Sep-Oct;30(5):768–773. [PubMed] [Google Scholar]
  9. Palacios I. F., Tuzcu E. M., Ziskind A. A., Younger J., Block P. C. Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc Diagn. 1991 Apr;22(4):244–249. doi: 10.1002/ccd.1810220403. [DOI] [PubMed] [Google Scholar]
  10. Palatianos G. M., Thurer R. J., Kaiser G. A. Comparison of effectiveness and safety of operations on the pericardium. Chest. 1985 Jul;88(1):30–33. doi: 10.1378/chest.88.1.30. [DOI] [PubMed] [Google Scholar]
  11. van Belle S. J., Volckaert A., Taeymans Y., Spapen H., Block P. Treatment of malignant pericardial tamponade with sclerosis induced by instillation of bleomycin. Int J Cardiol. 1987 Aug;16(2):155–160. doi: 10.1016/0167-5273(87)90246-4. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES